H.C. Wainwright Global Life Sciences Conference
Click here for full Press Release and Presentation
H.C. Wainwright Global Life Sciences Conference
Click here for full Press Release and Presentation
Recce Pharmaceuticals Ltd (ASX:RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health threat of antibiotic-resistant superbugs.
© 2025 Recce Pharmaceuticals